DEA Announcement Is A 'Missed Opportunity' Says Dr. Sanjay Gupta
Optimistic activists would say that the movement for marijuana legalization made a small gain last week when the Drug Enforcement Administration decided to expand marijuana research. But Sanjay Gupta - a neuroscientist who produced the Weed documentary series for CNN - suggests that the DEA's move probably won't make a big difference. In fact, new research projects might be geared toward reaffirming rather than challenging biases against cannabis.
Last week, DEA chief Chuck Rosenberg denied an application to loosen America's marijuana laws. Right now, cannabis is listed as a Schedule I drug in the Controlled Substances Act (CSA). That means the federal government defines it as a substance that has no medical value and is as dangerous as heroin. For decades, advocates have fought to have cannabis dropped to Schedule II so that it can be recognized as medicine. That change would basically mean downgrading cannabis from being considered as dangerous as heroin...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin